New device could help stroke patients recover hand function faster
NCT ID NCT05133232
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a device called SynPhNe that combines physical therapy with brain feedback to help stroke patients improve hand movement. Fifty-one recent stroke survivors used the device alongside standard therapy. The goal was to see if it could boost recovery and be used with less therapist help.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- SynPhNe physio-neuro platform (a device that combines physical therapy with brain feedback)
- What this could lead to
- If it works, this could offer a way for stroke patients to improve hand function with less therapist supervision, making rehab more efficient.
- What could go wrong
- This is a small, early feasibility study with only 51 participants. Results may not apply to all stroke patients, and the device may not be better than standard therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
51 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Hemiparetic stroke (haemorrhagic or ischaemic) within 4 months of recruitment; 2. FMA UE less than 55 (out of maximum of 66) but able to extend at least 2 fingers in the affected hand 10 degrees at any joint with pain-free passive range of motion at least 50% in all joints below the elbow; 3. Age 21-90. Exclusion criteria: 1. Cognitive or language impairment resulting in inability to follow instructions or inability to sustain attention for more than 10 minutes or inability to give consent; 2. Poor sitting balance (inability to sustain unsupported sitting for \> 10min) 3. Other orthopaedic or neurological diseases other than stroke affecting the function of the stroke-affected arm; 4. severe pain in the stroke affected upper limb 5. Terminal diseases with expected survival \<1 year 6. Women who are pregnant or breastfeeding 7. Patients who are in medically unstable conditions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stroke are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexandra hospital
Singapore, Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robot could let stroke patients rehab their hands at home without a therapist
- Moving patterns may help stroke survivors read faster
- Vibrating wearables put stroke walking to the test
- Robot plus electrical stimulation aims to rebuild arm movement after stroke
- Can a checklist and heart monitor stop repeat strokes?
- Heart hole or stroke trigger? global registry tracks who gets closure and what happens next